Stay updated with breaking news from Per Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biophytis (NASDAQ:BPTS, EPA:ALBPS) CEO Stanislas Veillet joined Steve Darling from Proactive to share news the company has released the full results from...
Biophytis (NASDAQ:BPTS, EPA:ALBPS) CEO Stanislas Veillet joined Steve Darling from Proactive to share news the company has released the full results from...
03.11.2022 - Biophytis / Key word(s): Study results Biophytis reports positive post-hoc analysis of the phase 2-3 COVA clinical study strongly supporting therapeutic potential of Sarconeos (BIO101) in COVID-19 03-Nov-2022 / 08:00 CET/CEST Biophytis reports ... Seite 1
Biophytis / Key word(s): Study resultsBiophytis reports positive post-hoc analysis of the phase 2-3 COVA clinical study strongly supporting therapeutic potential of Sarconeos (BIO101) in COVID-19 03-Nov-2022 / 08:00 CET/CEST Biophytis reports positive post-hoc analysis of the phase 2-3 COVA clinical study stron...
16.05.2022 - Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces the first presentation of the full data analysis from ... Seite 1